The newly developed variants with increased sensitivity and reprogrammed activity offer valuable tools for applications in synthetic biology and biotechnology. “The results obtained from this model system have general relevance for countless systems of this type, which regulate important bacterial responses such as development, movement and infectivity. In addition, we are creating systems that can be used directly in biotechnology, which allow the production of any proteins to be activated by red light,” explains Prof. Andreas Möglich.
The study was carried out in collaboration with the University of Jyväskylä, Finland, and was funded by the German Research Foundation and the EU project FET Open NEUROPA.
MEDICA-tradefair.com; Source: University of Bayreuth